Hajime Hosoi

7.0k total citations · 1 hit paper
189 papers, 5.1k citations indexed

About

Hajime Hosoi is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hajime Hosoi has authored 189 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 46 papers in Neurology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hajime Hosoi's work include Neuroblastoma Research and Treatments (40 papers), Sarcoma Diagnosis and Treatment (28 papers) and Acute Myeloid Leukemia Research (15 papers). Hajime Hosoi is often cited by papers focused on Neuroblastoma Research and Treatments (40 papers), Sarcoma Diagnosis and Treatment (28 papers) and Acute Myeloid Leukemia Research (15 papers). Hajime Hosoi collaborates with scholars based in Japan, United States and Canada. Hajime Hosoi's co-authors include Peter J. Houghton, Robert T. Abraham, Tohru Sugimoto, Tomoko Iehara, John C. Lawrence, Aleksandar Sekulić, Christine C. Hudson, Gregory J. Brunn, Kunihiko Tsuchiya and Takuma Shikata and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hajime Hosoi

181 papers receiving 5.0k citations

Hit Papers

Phosphorylation of the Tr... 1997 2026 2006 2016 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
    1997 801 citations Hajime Hosoi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajime Hosoi Japan 35 3.1k 981 835 803 649 189 5.1k
Cory M. Johannessen United States 17 2.9k 0.9× 1.3k 1.3× 432 0.5× 667 0.8× 405 0.6× 28 4.2k
Jennifer D. Black United States 37 3.1k 1.0× 985 1.0× 349 0.4× 499 0.6× 693 1.1× 94 4.7k
Hubert Hondermarck Australia 44 3.2k 1.0× 1.3k 1.3× 585 0.7× 1.0k 1.3× 250 0.4× 151 6.0k
Henrik Hager Denmark 35 2.7k 0.8× 780 0.8× 857 1.0× 1.5k 1.9× 362 0.6× 119 4.6k
Guillem Genové Sweden 27 3.4k 1.1× 1.1k 1.1× 551 0.7× 868 1.1× 617 1.0× 42 7.5k
Junichi Hamada Japan 37 2.2k 0.7× 1.2k 1.2× 446 0.5× 1.1k 1.4× 277 0.4× 154 4.3k
Lauren A. Langford United States 34 2.9k 0.9× 867 0.9× 530 0.6× 579 0.7× 435 0.7× 70 5.4k
Gilbert J. Cote United States 46 3.3k 1.1× 1.5k 1.6× 436 0.5× 1.2k 1.5× 542 0.8× 141 7.3k
Heidi Scrable United States 31 2.3k 0.7× 1.0k 1.0× 629 0.8× 511 0.6× 318 0.5× 51 4.6k

Countries citing papers authored by Hajime Hosoi

Since Specialization
Citations

This map shows the geographic impact of Hajime Hosoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Hosoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Hosoi more than expected).

Fields of papers citing papers by Hajime Hosoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Hosoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Hosoi. The network helps show where Hajime Hosoi may publish in the future.

Co-authorship network of co-authors of Hajime Hosoi

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Hosoi. A scholar is included among the top collaborators of Hajime Hosoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Hosoi. Hajime Hosoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arakawa, Yuki, Daisuke Hasegawa, Takako Miyamura, et al.. (2022). Postchemotherapy immune status in infants with acute lymphoblastic leukemia: A report from the JPLSG MLL‐10 trial. Pediatric Blood & Cancer. 69(10). e29772–e29772.
2.
Kunitomi, Chisato, Miyuki Harada, Yasushi Takai, et al.. (2022). The possible effects of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan. Reproductive Medicine and Biology. 21(1). 7 indexed citations
3.
Yagyu, Shigeki, et al.. (2021). Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma. Cancer Science. 112(10). 4026–4036. 14 indexed citations
4.
Hasegawa, Tatsuji, Koji Sakai, Takenori Tozawa, et al.. (2021). Low‐grade IVH in preterm infants causes cerebellar damage, motor, and cognitive impairment. Pediatrics International. 63(11). 1327–1333. 8 indexed citations
5.
Katsumi, Yoshiki, Tomoko Iehara, Hideki Yoshida, et al.. (2020). The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA. Molecular Cancer Therapeutics. 19(10). 1992–2000. 5 indexed citations
6.
Kuriyama, Nagato, Teruhide Koyama, Daisuke Matsui, et al.. (2020). Validity of stress assessment using heart‐rate variability in newborns. Pediatrics International. 62(6). 694–700. 9 indexed citations
7.
Imamura, Toshihiko, Kuniaki Tanaka, Itaru Kato, et al.. (2020). Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model. Leukemia. 35(7). 2092–2096. 4 indexed citations
8.
Miyachi, Mitsuru, Kunihiko Tsuchiya, Ako Hosono, et al.. (2019). Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma. Medicine. 98(52). e18344–e18344. 4 indexed citations
9.
Harada, Miyuki, Chisato Kunitomi, Gentaro Izumi, et al.. (2019). A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. Journal of obstetrics and gynaecology research. 45(10). 2021–2028. 16 indexed citations
10.
11.
Suzuki, Gen, Toshiyuki Ogata, Norihiro Aibe, et al.. (2019). Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report. Journal of Medical Case Reports. 13(1). 277–277. 6 indexed citations
12.
Kodo, Kazuki, Kenichi Sakamoto, Mitsuru Miyachi, et al.. (2018). Cytomegalovirus-associated biliary atresia. Journal of Pediatric Surgery Case Reports. 35. 17–20. 4 indexed citations
13.
Henssen, Anton G., Casie Reed, Heathcliff Dorado García, et al.. (2017). Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors. Science Translational Medicine. 9(414). 30 indexed citations
14.
Nakayama, Hideki, Daisuke Tomizawa, Shiro Tanaka, et al.. (2017). Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. Pediatrics International. 59(10). 1046–1052. 6 indexed citations
15.
Kakazu, Naoki, et al.. (2014). Identification of the 12q15 Amplicon within the Homogeneously Staining Regions in the Embryonal Rhabdomyosarcoma Cell Line RMS-YM. Cytogenetic and Genome Research. 142(3). 167–173. 2 indexed citations
16.
Miyachi, Mitsuru, Naoki Kakazu, Shigeki Yagyu, et al.. (2009). Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells. Clinical Cancer Research. 15(12). 4077–4084. 75 indexed citations
17.
Yagyu, Shigeki, Takahiro Gotoh, Tomoko Iehara, et al.. (2008). Circulating Methylated- DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma. Clinical Cancer Research. 14(21). 7011–7019. 34 indexed citations
18.
Osone, Shinya, Hajime Hosoi, Kunihiko Tsuchiya, et al.. (2008). Low-dose Protracted Irinotecan as a Palliative Chemotherapy for Advanced Neuroblastoma. Journal of Pediatric Hematology/Oncology. 30(11). 853–856. 3 indexed citations
19.
20.
Sugimoto, Tohru, Hisao Ueyama, Hajime Hosoi, et al.. (1991). Alpha‐smooth‐muscle actin and desmin expressions in human neuroblastoma cell lines. International Journal of Cancer. 48(2). 277–283. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cory M. Johannessen Breakdown of academic impact, for papers by Jennifer D. Black Breakdown of academic impact, for papers by Hubert Hondermarck Breakdown of academic impact, for papers by Henrik Hager Breakdown of academic impact, for papers by Guillem Genové Breakdown of academic impact, for papers by Junichi Hamada Breakdown of academic impact, for papers by Lauren A. Langford Breakdown of academic impact, for papers by Gilbert J. Cote Breakdown of academic impact, for papers by Heidi Scrable
Rankless by CCL
2026